Original Source(s)
Related Content
FDA approves first therapy for warm autoimmune hemolytic anemia
The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.
August 25, 2026
-
3 min
Coordinated oral–gut microbiota relocation in connective tissue diseases: a systematic review
by Verena Ida Meyer, Sylvio Redanz, Martin Alexander Kriegel
July 3, 2026